ID

23425

Description

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone; ODM derived from: https://clinicaltrials.gov/show/NCT00402909

Lien

https://clinicaltrials.gov/show/NCT00402909

Mots-clés

Versions (1)
  1. 04/07/2017 04/07/2017 -
Téléchargé le

4 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes NCT00402909

Anglais

Eligibility Type 2 Diabetes NCT00402909

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male/female, age 18-78 inclusive
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
type 2 diabetes, taking glargine, metformin and/or thiazolidinedione for 3 months prior to screening, stable doses for 2 months prior to screening
Description

Diabetes Mellitus, Non-Insulin-Dependent | Glargine Dose Stable | Metformin Dose Stable | Thiazolidinediones Dose Stable

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0907402
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [4,1]
C1257987
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
hba1c 7.0-8.5% inclusive
Description

Glycosylated hemoglobin A

Type de données

boolean

Alias
UMLS CUI [1]
C0019018
fasting plasma glucose <240 mg/dl at screening
Description

Plasma fasting glucose measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0583513
body mass index 22-41 kg/m2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or nursing
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
other investigational drugs within 30 days of screening
Description

Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0013230
treatment with other anti-diabetic medications other than metformin, glargine and/or thiazolidinedione
Description

Antidiabetics | Metformin | Glargine | Thiazolidinediones

Type de données

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2]
C0025598
UMLS CUI [3]
C0907402
UMLS CUI [4]
C1257987
history of type 1 diabetes
Description

Diabetes Mellitus, Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
abnormal kidney function
Description

Abnormal renal function

Type de données

boolean

Alias
UMLS CUI [1]
C0151746
history of acute diabetic complications
Description

Complications of Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0342257
congestive heart failure requiring treatment
Description

Congestive heart failure Treatment required for

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0332121
myocardial infarction, coronary artery surgery, stroke within 6 months of screening
Description

Myocardial Infarction | Coronary Artery Bypass Surgery | Cerebrovascular accident

Type de données

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0010055
UMLS CUI [3]
C0038454
liver disease, liver enzymes more than 3 times upper limit of normal
Description

Liver diseases | Elevated liver enzymes

Type de données

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0235996
fasting triglycerides >700 mg/dl within past 12 weeks
Description

Serum fasting triglyceride measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0582824
acute infections or other conditions that may affect blood sugar or may interfere with interpretation of study data
Description

Communicable Diseases Affecting Blood Glucose | Communicable Diseases Interfere with Interpretation research data | Condition Affecting Blood Glucose | Condition Interferes with Interpretation research data

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0005802
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0459471
UMLS CUI [2,4]
C0681873
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0005802
UMLS CUI [4,1]
C0348080
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0459471
UMLS CUI [4,4]
C0681873
treatment with corticosteroids
Description

Adrenal Cortex Hormones

Type de données

boolean

Alias
UMLS CUI [1]
C0001617
blood donation within past 12 weeks
Description

Blood Donation

Type de données

boolean

Alias
UMLS CUI [1]
C0005794
other protocol-defined inclusion/exclusion criterial may apply.
Description

Clinical Trial Eligibility Criteria Study Protocol

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Retour au début de la page

Similar models

Eligibility Type 2 Diabetes NCT00402909

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male/female, age 18-78 inclusive
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Glargine Dose Stable | Metformin Dose Stable | Thiazolidinediones Dose Stable
Item
type 2 diabetes, taking glargine, metformin and/or thiazolidinedione for 3 months prior to screening, stable doses for 2 months prior to screening
boolean
C0011860 (UMLS CUI [1])
C0907402 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0025598 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C1257987 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Glycosylated hemoglobin A
Item
hba1c 7.0-8.5% inclusive
boolean
C0019018 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fasting plasma glucose <240 mg/dl at screening
boolean
C0583513 (UMLS CUI [1])
Body mass index
Item
body mass index 22-41 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
other investigational drugs within 30 days of screening
boolean
C0013230 (UMLS CUI [1])
Antidiabetics | Metformin | Glargine | Thiazolidinediones
Item
treatment with other anti-diabetic medications other than metformin, glargine and/or thiazolidinedione
boolean
C0935929 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C0907402 (UMLS CUI [3])
C1257987 (UMLS CUI [4])
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Abnormal renal function
Item
abnormal kidney function
boolean
C0151746 (UMLS CUI [1])
Complications of Diabetes Mellitus
Item
history of acute diabetic complications
boolean
C0342257 (UMLS CUI [1])
Congestive heart failure Treatment required for
Item
congestive heart failure requiring treatment
boolean
C0018802 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Myocardial Infarction | Coronary Artery Bypass Surgery | Cerebrovascular accident
Item
myocardial infarction, coronary artery surgery, stroke within 6 months of screening
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
Liver diseases | Elevated liver enzymes
Item
liver disease, liver enzymes more than 3 times upper limit of normal
boolean
C0023895 (UMLS CUI [1])
C0235996 (UMLS CUI [2])
Serum fasting triglyceride measurement
Item
fasting triglycerides >700 mg/dl within past 12 weeks
boolean
C0582824 (UMLS CUI [1])
Communicable Diseases Affecting Blood Glucose | Communicable Diseases Interfere with Interpretation research data | Condition Affecting Blood Glucose | Condition Interferes with Interpretation research data
Item
acute infections or other conditions that may affect blood sugar or may interfere with interpretation of study data
boolean
C0009450 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0005802 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0459471 (UMLS CUI [2,3])
C0681873 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0005802 (UMLS CUI [3,3])
C0348080 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0459471 (UMLS CUI [4,3])
C0681873 (UMLS CUI [4,4])
Adrenal Cortex Hormones
Item
treatment with corticosteroids
boolean
C0001617 (UMLS CUI [1])
Blood Donation
Item
blood donation within past 12 weeks
boolean
C0005794 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criterial may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial